Gainers
- Shattuck Labs (NASDAQ:STTK) stock moved upwards by 93.8% to $4.09 during Wednesday's regular session. The company's market cap stands at $173.7 million.
- Reshape Lifesciences (NASDAQ:RSLS) stock rose 89.48% to $0.48. The market value of their outstanding shares is at $6.2 million.
- C4 Therapeutics (NASDAQ:CCCC) shares increased by 86.32% to $4.36. The company's market cap stands at $214.8 million.
- Avalo Therapeutics (NASDAQ:AVTX) shares moved upwards by 81.84% to $0.06. The company's market cap stands at $12.1 million.
- ACADIA Pharmaceuticals (NASDAQ:ACAD) shares increased by 35.38% to $28.66. The company's market cap stands at $4.7 billion.
- Know Labs (AMEX:KNW) stock increased by 26.72% to $0.73. The company's market cap stands at $59.0 million.
Losers
- OneMedNet (NASDAQ:ONMD) shares decreased by 21.7% to $0.8 during Wednesday's regular session. The company's market cap stands at $25.8 million.
- Processa Pharma (NASDAQ:PCSA) stock fell 19.84% to $0.65. The company's market cap stands at $16.0 million.
- Redhill Biopharma (NASDAQ:RDHL) shares fell 18.94% to $1.07. The company's market cap stands at $21.0 million.
- Protagenic Therapeutics (NASDAQ:PTIX) stock declined by 18.19% to $0.81. The market value of their outstanding shares is at $3.5 million.
- Silence Therapeutics (NASDAQ:SLN) shares declined by 16.98% to $12.81. The company's market cap stands at $495.3 million.
- Black Diamond Therapeutic (NASDAQ:BDTX) shares fell 15.26% to $2.44. The company's market cap stands at $126.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AVTXAvalo Therapeutics Inc
$14.991.28%
BDTXBlack Diamond Therapeutics Inc
$2.40-%
CCCCC4 Therapeutics Inc
$2.18-%
ONMDOneMedNet Corp
$0.9100-2.30%
PCSAProcessa Pharmaceuticals Inc
$3.18-1.85%
PTIXProtagenic Therapeutics Inc
$0.5007-61.5%
RDHLRedhill Biopharma Ltd
$1.4712.2%
SLNSilence Therapeutics PLC
$5.10-1.92%
STTKShattuck Labs Inc
$4.30-0.92%
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
